Argos Therapeutics, Inc. (ARGS) will report its next earnings on Aug 09. The company reported the earnings of $-0.19/Share in the last quarter where the estimated EPS by analysts was $-0.26/share. The difference between the expected and actual EPS was $0.07/share, which represents an Earnings surprise of 26.9%.
Many analysts are providing their Estimated Earnings analysis for Argos Therapeutics, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.18/share. These analysts have also projected a Low Estimate of $-0.2/share and a High Estimate of $-0.15/share.
In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for Argos Therapeutics, Inc. as 100 Million. According to these analysts, the Low Revenue Estimate for Argos Therapeutics, Inc. is 100 Million and the High Revenue Estimate is 100 Million. The company had Year Ago Sales of 147 Million.
Some buy side analysts are also providing their Analysis on Argos Therapeutics, Inc., where 3 said it’s a HOLD. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Argos Therapeutics, Inc. might touch $0.75 high while the Average Price Target and Low price Target is $0.75 and $0.75 respectively.
Argos Therapeutics, Inc. closed its last trading session at $0.19 with the gain of 5.64%. The Market Capitalization of the company stands at 11.51 Million. The Company has 52-week high of $5.68 and 52-week low of $0.18. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -18.6% where SMA50 and SMA200 are -36.75% and -90.57% respectively. The Company Touched its 52-Week High on 01/09/17 and 52-Week Low on 08/17/17.
The Relative Volume of the company is 2.39 and Average Volume (3 months) is 1.7 million.
The company shows its Return on Assets (ROA) value of -92%. While it’s Return on Investment (ROI) value is -96.3%.
While looking at the Stock’s Performance, Argos Therapeutics, Inc. currently shows a Weekly Performance of -9.77%, where Monthly Performance is -34.53%, Quarterly performance is -54.94%, 6 Months performance is -86.54% and yearly performance percentage is -95.38%. Year to Date performance value (YTD perf) value is -95.95%. The Stock currently has a Weekly Volatility of 11.64% and Monthly Volatility of 12.73%.